Hypertension Trial, Recruiting NCT05655065 Sponsor: University Hospital, Angers Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT05655065
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People who have dangerously low blood pressure that requires medication (called catecholamines) to keep it at a safe level
  • People who are receiving a specific blood pressure medication (norepinephrine) at a dose of 0.1 micrograms per kilogram per minute or higher at the time of joining the trial
  • People who have a high pressure reading in a central vein (a major vein near the heart), measuring 12 mmHg or above
  • People who are already having their heart's output (how much blood the heart pumps) measured using a specialised monitoring device (either a PiCCO or Swan-Ganz monitor)

Who may not be able to join:

  • People whose kidneys have completely stopped producing urine
  • People who urgently need kidney dialysis or a similar treatment — for example, due to dangerously high potassium levels, severe blood acid imbalance, severe fluid buildup in the lungs causing breathing problems, or very high levels of urea in the blood
  • Women who are pregnant, breastfeeding, or in labour
  • People who are detained or held under a court or government order
  • People who are receiving compulsory psychiatric treatment
  • People who are under a legal guardianship or protection order
  • People who have a do-not-resuscitate order in place, or for whom a decision has been made to withdraw life-sustaining treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pierre ASFAR, MD PhD, University Hospital, Angers

Phone: +332 41 35 36 37

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Angers
Registry
ClinicalTrials.gov
Start date
2 January 2023
Est. completion
31 December 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Changes of creatinine clearance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov